Omeros reports q1 loss per share $0.53

Omeros corporation reports first quarter 2020 financial results.q1 loss per share $0.53.q1 revenue $23.5 million.q1 revenue estimate $30.3 million -- refinitiv ibes data.q1 earnings per share estimate $-0.34 -- refinitiv ibes data.continue targeting data readout for iga nephropathy trial next year.on track to file a clinical trial application this quarter for company's masp-3 inhibitor oms906.as of march 31, had $54.0 million of cash, cash equivalents and short-term investments available for operations.
OMER Ratings Summary
OMER Quant Ranking